Patent · US Expired

Oxime derivatives and their use as pharmaceutically active agents

US7173060B2 · kind B2 · utility

0Cited by

4References

12Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Georg Fertig · Penzberg, DE
Frank Herting · Penzberg, DE
Manfred Kubbies · Penzberg, DE
Anja Limberg · Penzberg, DE
Ulrike Reiff · Penzberg, DE
Michael Weidner · Sunrise, US

Key dates

Filing date	Mar 31, 2004
Grant date	Feb 6, 2007
Priority date	—
Expiry date	Aug 2, 2025

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula I,their pharmaceutically acceptable salts as well as their enantiomeric forms, diastereoisomers and racemates; the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds as inhibitors of histone deacetylase (HDAC) and therefore in the control or prevention of illnesses and disorders as mentioned above, or in the manufacture of corresponding pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.